To investigate the effect of PAQR5 on the tumor immune microenvironment, the T-cell-mediated killing assay was performed to assess whether the upregulation of PAQR5 in HCC affects T-cell function. The gene discussed is PAQR5; the disease is hepatocellular carcinoma.